|
1.Ichikawa, Y. Differentiation of a cell line of myeloid leukemia. J. Cell Physiol. 74: 223-34, 1969.
2.Friend, C.; Scher, W.; Holland, J. G.; Sato, T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proceedings of the National Academy of Sciences of the United States of America. 68(2): 378-82, 1971.
3.Collins, S. J.; Ruscetti, F. W.; Gallagher, R. E.; Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proceedings of the National Academy of Sciences of the United States of America. 75(5): 2458-62, 1978.
4.Gallagher, R.; Collins, S.; Trujillo, J.; McCredie, K.; Ahearn, M.; Tsai, S.; Metzgar, R.; Aulakh, G.; Ting, R.; Ruscetti, F.; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54(3): 713-33, 1979.
5.Breitman, T. R.; Selonick, S. E.; Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proceedings of the National Academy of Sciences of the United States of America. 77(5): 2936-40, 1980.
6.Breitman, T. R.; Collins, S. J.; Keene, B. R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood. 57(6): 1000-4, 1981.
7.Koeffler, H. P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 62: 709-721, 1983.
8.Lanotte, M.; Martin-Thouvenin, V.; Najman, S.; Balerini, P.; Valensi, F.; Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 77(5): 1080-6, 1991.
9.2000, 42nd Annual Meeting of the American Society of Hematology
10.Norman, A. W.; Zhou, J. Y.; Henry, H. L.; Uskokovic, M. R.; Koeffler, H. P. Structure-function studies on analogues of 1 alpha, 25- dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Research. 50(21): 6857-64, 1990.
11.Hozumi, M. Fundamentals of Chemo-differentiation therapy of myeloid leukemia. Anticancer Research. 14: 1177-92, 1994.
12.Samid, D.; Yeh, A.; Prasanna, P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood. 80(6): 1576-81, 1992.
13.Jing, Y.; Waxman, S. Structural requirements for differentiation-
induction and growth-inhibition of mouse erythroleukemia cells by isoflavones. Anticancer Research. 15(4): 1147-52, 1995.
14.Mizutani, Y.; Masuoka, S.; Imoto, M.; Kawada, M.; Umezawa, K. Induction of erythroid differentiation in leukaemic K562 cells by an S-adenosylhomocysteine hydrolase inhibitor, aristeromycin. Biochemical & Biophysical Research Communications. 207(1): 69-74, 1995.
15.Jing, Y.; Wang, L.; Xia, L.; Chen, Guo-qiang; Chen, Zhu.; Miller, W.
H.; and Waxman, S. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood. 97: 264-269, 2001.
16.Numazawa, S.; Shinoki, M. A.; Ito, H.; Yoshida, T.; Kuroiwa, Y. Involvement of Na+, K+-ATPase inhibition in K562 cell differentiation induced by bufalin. Journal of Cellular Physiology. 160(1): 113-20, 1994.
17.Sato, S.; Tomoyasu, S.; Okabe-Kado, J.; Hozumi, M.; Tsuruoka, N.; Nakai, S.; Adachi, M.; Honma, Y. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent. Experimental Hematology. 24(1): 37-42, 1996.
18.Degos, L. All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia. [Review] Biomedicine & Pharmacotherapy. 46(5-7): 201-9, 1992.
19.Castaigne, S.; Chomienne, C.; Daniel, M. T.; Ballerini, P.; Berger, R.; Fenaux, P.; Degos, L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76(9): 1704-9, 1990.
20.Fiorella, P. D.; Giguere, V.; Napoli, J. L. Expression of cellular retinoic acid-binding protein (type II) in Escherichia coli. Characterization and comparison to cellular retinoic acid-binding protein (type I). Journal of Biological Chemistry. 268(29): 21545-52, 1993.
21.Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. [Review] Endocrine Reviews. 15(1): 61-79, 1994.
22.Lefebvre, P.; Thomas, G.; Gourmel, B.; Agadir, A.; Castaigne, S.; Dreux, C.; Degos, L.; Chomienne, C. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Leukemia. 5(12): 1054-8, 1991.
23.Frankel, S. R.; Eardley, A.; Lauwers, G.; Weiss, M.; Warrell, R. P. Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Annals of Internal Medicine. 117(4): 292-6, 1992.
24.Sakurai, M.; Sampi, K.; Hozumi, M. Possible differentiation of human acute myeloblastic leukemia cells by daily and intermittent administration of aclacinomycin-A. Leukemia Research. 7(2): 139-43, 1983.
25.Housset, M.; Daniel, M. T.; Degos, L. Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? British Journal of Haematology. 51(1): 125-9, 1982.
26.Engvild, K. C. The death hormone hypothesis. Physiol Plant.; 77 282-5, 1989.
27.Folkes, L. K.; Dennis, M. F.; Stratford, M. R.; Candeias, L. P.; Wardman, P. Peroxidase-catalyzed effects of indole-3-acetic acid and analogues on lipid membranes, DNA, and mammalian cells in vitro. Biochemical Pharmacology. 57(4): 375-82, 1999.
28.Folkes, L. K.; Wardman, P. Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochemical Pharmacology. 61(2): 129-36, 2001.
29.Folkes, L. K.; Candeias, L. P.; Wardman, P. Toward targeted "oxidation therapy" of cancer: peroxidase-catalysed cytotoxicity of indole-3-acetic acids. International Journal of Radiation Oncology, Biology, Physics. 42(4): 917-20, 1998.
30.Napier, M. P.; Sharma, S. K.; Springer, C. J.; Bagshawe, K. D.; Green, A. J.; Martin, J.; Stribbling, S. M.; Cushen, N.; O'Malley, D.; Begent, R. H. Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma. Clinical Cancer Research. 6(3): 765-72, 2000.
31. Bagshawe, K. D.; Sharma, S. K.; Springer, C. J.; Rogers, G. T. Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects. [Review] Annals of Oncology. 5(10): 879-91, 1994.
32.Melton, R. G.; Sherwood, R. F. Antibody-enzyme conjugates for cancer therapy. [Review] Journal of the National Cancer Institute. 88(3-4): 153-65, 1996.
33.M. C. Liau , L. J. Huang J.H Lee. S.C Chen and S. C.K. Development of Differentiation Helper .Inducers for the Differentiation Therapy of Cancer.Chin pharm J. 50, 289-3-3(1998).
34.Ihara, Masataka; Noguchi, Kazuharu; Fukumoto,
Keiichiro; Kametani, Tetsuji; Heterocycles; 20; 3; 1983; 421-424.
35.Avoian , A. A.; Afrikia , V. G.; Babiian , N. A.; Mndzhoian , O. L.; Tatevosian , G. T. Syntheses of Heterocyclic Compounds Volume 2 ;(48-50).
36.趙逸儒 Synthesis of Certain Indole-3-Acetamides as Cell Differentiation Inducer. 中國醫藥學院藥物化學研究所 碩士論文。
|